Zhongyuan Xiehe will cooperate with Nobel Prize winners to build an international research and development platform for cell biotherapy

According to the public information, in December 2012, the company's subsidiaries and zebio signed a patent technology exclusive license agreement with British cell therapy Co., Ltd represented by Martin, the Nobel Prize winner According to the agreement, British cell therapy Co., Ltd granted the company its own clinical patent technology for the treatment of heart failure with autologous mesodermal stromal cells For this cooperation, the market people think that the company may have an updated cooperation agreement in this regard In order to further verify the specific situation, the big smart news agency called the Secretary of directors office The company people said that this cooperation is only academic exchange, and there may be new technical project cooperation in the future The company is a biomedical enterprise mainly engaged in stem cell resource collection and storage technology services, and is the only listed company in the field of stem cells in China.